MR-Pathological Comparison in F98-Fischer Glioma Model Using a Human Gantry

ABSTRACT: Object: This study reports our findings in assessing in vivo tumour growth with magnetic resonance imaging using a commercial magnet and antenna in F98 implanted Fischer rats. A comparison of T1 gadolinium-enhanced coronal MR scans and pathology specimens in corresponding animals was accomplished. Methods: One rat was used in serial experiments to establish adequate imaging parameters. Afterward, 12 animals implanted with F98 cells underwent a MR study following intervals spanning five, ten, 15 and 20 days on a 1.5T human Siemens. Using a small loop antenna, a coronal T1 weighted MRI scan with Gadolinium was performed. Images were analyzed and volumes of enhancing tumour were calculated. The animals were sacrificed after the imaging procedure and brain were harvested and processed in pathology. Pathology specimens and MR images were analyzed using image processing software. One hematoxylin + eosin (H&E) slide per specimen was compared to the corresponding MR slice depicting the largest area of enhancement. Results: The MR enhancement areas obtained were 2.18mm2, 8.25mm2, 21.6mm2 and 23.17mm2 at five, ten, 15 and 20 days. Tumour margin measurements on pathologic samples produced areas of 0.29mm2, 4.43 mm2, 8.3mm2, and 12.9mm2 at five, ten, 15 and 20 days respectively. Conclusion: The T1-enhancing images constantly overestimated the tumour bulk on H&E. This phenomenon is explained by enhancement of the brain around tumour, the extra-axial tumour growth, and a shrinking factor of 17% related to the fixation process. Nonetheless, the radiological tumour growth paralleled the histological samples. This technology is thus suitable to follow tumour growth in F98 implanted rats.

[1]  J. Benoit,et al.  Therapeutic effectiveness of novel 5‐fluorouracil‐loaded poly(methylidene malonate 2.1.2)‐based microspheres on F98 glioma‐bearing rats , 2003, Cancer.

[2]  Rolf F. Barth,et al.  Rat brain tumor models in experimental neuro-oncology:The 9L, C6, T9, F98, RG2 (D74), RT-2 and CNS-1 Gliomas , 2004, Journal of Neuro-Oncology.

[3]  D. Burstein,et al.  Magnetic resonance imaging of patched heterozygous and xenografted mouse brain tumors , 2003, Journal of Neuro-Oncology.

[4]  Jennifer A. Smith,et al.  Response of rat intracranial 9L gliosarcoma to microbeam radiation therapy. , 2002, Neuro-oncology.

[5]  Ralf-Ingo Ernestus,et al.  Identification of intracranial liqor metastases of experimental stereotactically implanted brain tumors by the tumor-selective MRI contrast agent MnTPPS , 1992, Clinical & Experimental Metastasis.

[6]  J. Bruce,et al.  Interleukin-12-based Immunotherapy against Rat 9L Glioma , 1998 .

[7]  T. Chenevert,et al.  Contributions of cell kill and posttreatment tumor growth rates to the repopulation of intracerebral 9L tumors after chemotherapy: an MRI study. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[8]  M Hoehn-Berlage,et al.  High resolution quantitative relaxation and diffusion mri of three different experimental brain tumors in rat , 1995, Magnetic resonance in medicine.

[9]  E. Alexander,et al.  Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial. , 1978, Journal of neurosurgery.

[10]  William C. Broaddus,et al.  Determination of intracranial tumor volumes in a rodent brain using magnetic resonance imaging, Evans Blue, and histology: a comparative study , 2000, IEEE Transactions on Biomedical Engineering.

[11]  Andreas Wree,et al.  Local cerebral glucose utilization in perfusion-fixed rat brains , 1995, Journal of Neuroscience Methods.

[12]  G. Sutherland,et al.  Correlation between Gd-enhanced MR imaging and histopathology in treated and untreated 9L rat brain tumors. , 1995, Magnetic resonance imaging.

[13]  L. Ko,et al.  Morphological characterization of nitrosourea-induced glioma cell lines and clones , 2004, Acta Neuropathologica.

[14]  P. Vrignaud,et al.  Assessment of the experimental model of transplanted C6 glioblastoma in wistar rats , 1989, Journal of Neuro-Oncology.

[15]  G Le Duc,et al.  Use of T2‐weighted susceptibility contrast MRI for mapping the blood volume in the glioma‐bearing rat brain , 1999, Magnetic resonance in medicine.

[16]  X. Liu,et al.  MR imaging in rat glioma model and gene therapy using EGFR antisence RNA. , 1998, Chinese medical journal.

[17]  U. Schmiedl,et al.  Dyke Award Paper. Kinetics of pathologic blood-brain-barrier permeability in an astrocytic glioma using contrast-enhanced MR. , 1992, AJNR. American journal of neuroradiology.

[18]  E. Oldfield,et al.  Selective opening of the blood-tumor barrier by a nitric oxide donor and long-term survival in rats with C6 gliomas. , 2003, Journal of neurosurgery.

[19]  D. Montaudon,et al.  Effects of the combination of camptothecin and doxorubicin or etoposide on rat glioma cells and camptothecin-resistant variants , 2001, British Journal of Cancer.

[20]  Arvid Lundervold,et al.  Imaging of Experimental Rat Gliomas Using a Clinical MR Scanner , 2003, Journal of Neuro-Oncology.

[21]  B. Ross,et al.  Magnetic Resonance Imaging of Ethyl-nitrosourea-induced Rat Gliomas: A Model for Experimental Therapeutics of Low-grade Gliomas , 2001, Journal of Neuro-Oncology.

[22]  C. Orosz,et al.  Phenotype and functional activity of tumor-infiltrating lymphocytes isolated from immunogenic and nonimmunogenic rat brain tumors. , 1991, Cancer research.

[23]  N Allen,et al.  An improved rat brain-tumor model. , 1980, Journal of neurosurgery.

[24]  E. Perkins,et al.  Sequential Imaging and Volumetric Analysis of an Intracerebral C6 Glioma by Means of a Clinical MRI System , 1999, Journal of Neuro-Oncology.

[25]  F. Starr,et al.  Measurement of blood‐brain barrier permeability in a tumor model using magnetic resonance imaging with gadolinium‐dtpa , 1992, Magnetic resonance in medicine.